⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Transplantation After Complete Response In Patients With T-cell Lymphoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Transplantation After Complete Response In Patients With T-cell Lymphoma

Official Title: Transplantation After Complete Response In Patients With T-cell Lymphoma

Study ID: NCT05444712

Study Description

Brief Summary: Peripheral T-cell lymphoma (PTCL) encompasses a broad range of post-thymic (i.e., mature) sub-entities as defined by the 2017 WHO classification. The most common entities are angioimmunoblastic T-cell lymphoma (AITL) and other Tfh-phenotype PTCL or PTCL not otherwise specified (NOS), each representing approximately 20 to 25% of mature T- and NK/T-cell lymphomas. Compared to their B-cell counterparts, most PTCL confer dismal prognosis. In fact, except for anaplastic lymphoma kinase (ALK)-positive systemic anaplastic large cell lymphoma (sALCL), 10-year overall survival for patients with PTCL barely exceeds 30%. Given the infrequency and the heterogeneity of these malignancies, no real consensus on first-line treatment has been established for most PTCL. The place of autologous stem cell transplantation (ASCT) as a consolidation procedure for patients with PTCL achieving a complete metabolic response after induction is still highly debated. ESMO recommendations and recent guidelines from a committee of the American Society for Blood and Marrow Transplantation currently propose ASCT as first-line therapy for transplant-eligible patients for all patients reaching at least a partial response (PR) after induction. NCCN guidelines (version 2.2017) recommend ASCT or observation in case of metabolic CR but salvage regimen in case of residual disease after induction.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Chu D'Amiens - Hopital Sud, Amiens, , France

Chu D'Angers, Angers, , France

Ch Victor Dupouy, Argenteuil, , France

Ch D'Avignon - Hopital Henri Duffaut, Avignon, , France

Ch de La Cote Basque, Bayonne, , France

Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, , France

Ch Metropole Savoie - Site Chambery, Chambéry, , France

Chu Estaing, Clermont-Ferrand, , France

Ch Alpes Leman, Contamine sur Arve, , France

Hopital Henri Mondor, Creteil, , France

René Olivier Casasnovas, Dijon, , France

CHU Francois MITTERRAND, Dijon, , France

Ch de Dunkerque, Dunkerque, , France

Chd de Vendee, La Roche-sur-Yon, , France

Ch de Versailles - Hopital Andre Mignot, Le Chesnay, , France

CHU du Mans, Le Mans, , France

Service Oncologie médicale, HOPITAL SAINT VINCENT-DE-PAUL, Lille, , France

Service Hématologie Clinique et Thérapie Cellulaire, CHU DE LIMOGES - HOPITAL DUPUYTREN,, Limoges, , France

Centre Leon Berard, Lyon, , France

Chu de Montpellier, Montpellier, , France

Chu de Nantes, Nantes, , France

Centre Antoine Lacassagne, Nice, , France

Chu de Nimes - Hopital Caremeau, Nîmes, , France

Chr Orleans, Orléans, , France

Hopital Cochin, Paris, , France

Hopital de La Pitie Salpetriere, Paris, , France

Hopital Necker, Paris, , France

Hopital Saint Antoine, Paris, , France

Ch de Perpignan, Perpignan, , France

Chu de Bordeaux - Hopital Haut-Leveque, Pessac, , France

Chu Lyon-Sud, Pierre Benite, , France

Ch Annecy Genevois, Pringy, , France

Ch Perigueux, Périgueux, , France

Chu Pontchaillou_Rennes, Rennes, , France

Ch de Roubaix - Hopital Victor Provo, Roubaix, , France

Centre Henri Becquerel, Rouen, , France

Service Hématologie, Institut Curie - Hôpital René HUGUENIN, Saint-Cloud, , France

Chu de La Reunion - Hopital Felix Guyon, Saint-Denis, , France

Chu de La Reunion - Ghsr, Saint-Pierre, , France

Institut Cancerologie & Hematologie St-Etienne, Saint-Priest-en-Jarez, , France

Ch de Saint-Quentin, Saint-Quentin, , France

Hôpitaux Universitaires de Strasbourg, Strasbourg, , France

Institut Universitaire du Cancer, Toulouse, , France

Chu Bretonneau, Tours, , France

Ch de Valence, Valence, , France

Ch de Valenciennes - Hopital Jean Bernard, Valenciennes, , France

Chu Brabois, Vandœuvre-lès-Nancy, , France

Institut Gustave Roussy, Villejuif, , France

Contact Details

Name: Emmanuel BACHY, Pr

Affiliation: HCL

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: